Related references
Note: Only part of the references are listed.The Immunoscore: Colon Cancer and Beyond
Helen K. Angell et al.
CLINICAL CANCER RESEARCH (2020)
Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation
Vanda Toldi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Screening for Colon Cancer in Older Adults: Risks, Benefits, and When to Stop
Judy Nee et al.
MAYO CLINIC PROCEEDINGS (2020)
Expression and clinical significance of p62 protein in colon cancer
Cheng Lei et al.
MEDICINE (2020)
High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer
Fei Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
Honghai Ma et al.
SCIENTIFIC REPORTS (2019)
Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression
Chenju Xing et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1
Simon J. de Veer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma
Bonan Lin et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Small molecule inhibitors of mesotrypsin from a structure-based docking screen
Olumide Kayode et al.
PLOS ONE (2017)
被撤回的出版物: Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer (Retracted article. See vol.37, pg. 16399, 2016)
Sima Azizmohammadi et al.
TUMOR BIOLOGY (2016)
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy
Itay Cohen et al.
BIOCHEMICAL JOURNAL (2016)
PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer
Ruiqiong Ma et al.
GYNECOLOGIC ONCOLOGY (2015)
Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates
Alexandre P. Alloy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mesotrypsin and Caspase-14 Participate in Prosaposin Processing POTENTIAL RELEVANCE TO EPIDERMAL PERMEABILITY BARRIER FORMATION
Mami Yamamoto-Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer
Alexandra Hockla et al.
MOLECULAR CANCER RESEARCH (2012)
Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109
Alexandra Hockla et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Absence of mesotrypsinogen gene (PRSS3) copy number variations in patients with chronic pancreatitis
Emmanuelle Masson et al.
PANCREAS (2008)
Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin
Moh'd A. Salameh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia
Wolfgang Knecht et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor-1, but not proteinase-activated receptor-2, in rat astrocytes
Yingfei Wang et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Human mesotrypsin exhibits restricted S1′ subsite specificity with a strong preference for small polar side chains
Edit Szepessy et al.
FEBS JOURNAL (2006)
Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer
CJ Marsit et al.
MOLECULAR CARCINOGENESIS (2005)
Interchromosomal segmental duplications explain the unusual structure of PRSS3, the gene for an inhibitor-resistant trypsinogen
L Rowen et al.
MOLECULAR BIOLOGY AND EVOLUTION (2005)